Cardiac risk assessment before non-cardiac surgery

European Heart Journal Cardiovascular Imaging

Volumn 14, Issue 4, 2013, Pages 316-322

  Pannell, Laura M K ^a   Reyes, Eliana M ^a   Underwood, S Richard ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

non cardiac surgery; Risk assessment

Indexed keywords

ANTICOAGULANT AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CATECHOLAMINE; CLONIDINE; CREATINE KINASE; DOBUTAMINE; GLYCOSYLATED HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OPIATE; PLACEBO; TROPONIN;

ANGIOCARDIOGRAPHY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CREATINE KINASE BLOOD LEVEL; ECG ABNORMALITY; EMERGENCY SURGERY; EXERCISE ELECTROCARDIOGRAPHY; FUNCTIONAL STATUS; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HEMODYNAMIC STRESS; HIGH RISK PATIENT; HUMAN; HYPOTENSION; METABOLIC EQUIVALENT; MYOCARDIAL PERFUSION IMAGING; NONCARDIAC SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCINTIGRAPHY; STRESS ECHOCARDIOGRAPHY; SURGERY; SURGICAL RISK; VALVULAR HEART DISEASE; VASCULAR SURGERY;

CARDIOVASCULAR DISEASES; CORONARY STENOSIS; DIAGNOSTIC IMAGING; FEMALE; HUMANS; INCIDENCE; MALE; MYOCARDIAL INFARCTION; PREOPERATIVE CARE; PROGNOSIS; RISK ASSESSMENT; SURGICAL PROCEDURES, OPERATIVE; SURVIVAL RATE;

EID: 84875176130     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ehjci/jes288     Document Type: Review

References (44)

1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM et al. American Heart Association. Heart disease and stroke statistics-2011 update. Circulation 2011;123:e18-e20.
2. British Medical Journal. Best Practice. Preoperative cardiac risk assessment. http ://bestpractice.bmj.com/best-practice/monograph/954.html (15 January 11, date last accessed).
3. European Society Cardiology. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J 2009;30:2769-812.
4. Sicari R. Perioperative risk stratification in non cardiac surgery: role of pharmacological stress echocardiography. Cardiovasc Ultrasound 2004;2:4.
5. Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008;371:1839-47.
6. Palda VA, Detsky AS. Perioperative assessment and management of risk from coronary artery disease. Ann Intern Med 1997;127:313-28.
7. Mukherjee D, Eagle KA. Perioperative cardiac assessment for noncardiac surgery: eight steps to the best possible outcome. Circulation 2003;107:2771-4.
8. Fleisher LA, Beckman JA, Brown KA. ACC/AHA 2007 Guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2007;116:1971-96.
9. Goldman L, Caldera DL, Nussbaum SR, Southwick FS, Krogstad D, Murray B et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977;297:845-50.
10. Detsky AS, Abrams HB, McLaughlin JR, Drucker DJ, Sasson Z, Johnston N. Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med 1986;1:211-9.
11. Lee DH. Revised cardiac risk index. Circulation 1999;100:1043-9.
12. Schouten O, Bax JJ, Poldermans D. Assessment of cardiac risk before non-cardiac general surgery. Heart 2006;92:1866-72.
13. Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990;72:153-84.
14. Boersma E, Kertai MD, Schouten O, Bax JJ, Noordzij P, Steyeberg EW et al. Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. Am J Med 2005;118:1134-41.
15. Gersh BJ, Rihal CS, Rooke TW, Ballard JD. Evaluation and management of patients with both peripheral vascular and coronary artery disease. J Am Coll Cardiol 1991;18:203-14.
16. Leppo JA, Dahlberg ST. Imaging for preoperative risk stratification. In Zaret BL, Beller GA (eds). Clinical Nuclear Cardiology, 3rd ed. Philadelphia: Elsevier Mosby; 2005 pp. 323-38.
17. Hlatky MA, Boineau RE, Higginbotham MB, Lee KL, Mark DB, Califf RM et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol 1989;64:651-4.
18. Pasternak PF, Imparato AM, Bear G, Riles TS, Baumann FG, Benjamin D et al. The value of radionuclide angiography as a predictor of perioperative myocardial infarction in patients undergoing abdominal aortic aneurysm resection. J Vasc Surg 1984;1:2320-5.
19. Kertai MD. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart 2003;89:1327-34.
20. Baron JF, Mundler O, Bertrand M, Vicaut E, Barre E, Godet G et al. Dipyridamole-thallium scintigraphy and gated radionuclide angiography to assess cardiac risk before abdominal aortic surgery. N Engl J Med 1994;330: 663-9.
21. McPhail N, Calvin JE, Shariatmadar A. The use of preoperative exercise testing to predict cardiac complications after arterial reconstruction. J Vasc Surg 1988;1: 60-8.
22. Cutler BS, Wheeler HB, Paraskos JA, Cardullo PA. Applicability and interpretation of electrocardiographic stress testing in patients with peripheral vascular disease. Am J Surg 1981;141:501-6.
23. Boucher CA, Brewster DC, Darling RC Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery. N Eng J Med 1985;312:389-94
24. Leppo J, Plaja J, Gionet M, Tumolo J, Paraskos JA, Cutler BS et al. Noninvasive evaluation of cardiac risk before elective vascular surgery. J Am Coll Cardiol 1987;9:269-76.
25. Vanzetto G, Machecourt J, Blendea D. Additive value of thallium single-photon emission computed tomography myocardial imaging for prediction of perioperative events in clinically selected high cardiac risk patients having abdominal aortic surgery. Am J Cardiol 1996;77:143-8.
26. Eagle KA, Coley CM, Newell JB, Brewster DC, Darling RC, Strauss HW et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989;110:859-66.
27. Etchells E, Meade M, Tomlinson G, Cook D. Semiquantitative dipyridamole myocardial stress perfusion imaging for cardiac risk assessment before noncardiac vascular surgery: a metaanalysis. J Vasc Surg 2002;36:534-40.
28. Stratmann HG, Younic LT, Wittry MD. Dipyridamole technetium 99m sestamibi myocardial tomography for preoperative cardiac risk stratification before major or minor nonvascular surgery. Am Heart J 1996;132:536-41.
29. Wong CF, Little MA, Vinjamuri S. Technetium myocardial perfusion scanning in prerenal transplant evaluation in the United kingdom. Transplant Proc 2008;40: 1324-8.
30. Hashimoto J. Preoperative risk stratification using stress myocardial perfusion scintigraphy with electrocardiographic gating. J Nucl Med 2003;44: 385-90.
31. Underwood SR, Anagnostopoulos C, Cerqueira MD, Ell PJ, Flint EJ, Harbinson M et al. Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med 2004;31: 261-91.
32. Hachamovitch R, Rozanski A, Shaw LJ, Stone GW, Thomson LE, Friedman JD et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J 2011;32:1012-24.
33. Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden. Results from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial nuclear substudy. Circulation 2008;117:1283-91.
34. Poldermans D, Arnese M, Fioretti PM. Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography. J Am Coll Cardiol 1995;26:648-53.
35. Pasquet A, D'Hondt AM, Verhelst R, Vanoverschelde JL, Merlin J, Marwick TH et al. Comparison of dipyridamole stress echocardiography and perfusion scintigraphy for cardiac risk stratification in vascular surgery patients. Am J Cardiol 1998;82:1468-74.
36. Shaw LJ, Eagle KA, Gersh BJ, Miller DD. Meta-analysis of intravenous dipyridamole-thallium-201 imaging (1985-94) and dobutamine echocardiography (1991-94) for risk stratification before vascular surgery. J Am Coll Cardiol 1996;27: 787-98.
37. Rerkpattanapipat P, Morgan TM, Neagle CM, Link KM, Hamilton CA, Hundley WG et al. Assessment of preoperative cardiac risk with magnetic resonance imaging. Am J Cardiol 2002;90:416-9.
38. Danias PG, Roussakis A, Ioannidis JP. Diagnostic performance of coronary magnetic resonance angiography as compared against conventional X-ray angiography: a meta-analysis. J Am Coll Cardiol 2004;44:1867-76.
39. Ghadri JR, Fiechter M, Veraguth K, Gebhard C, Pazhenkottil AP, Fuchs TA et al. Coronary calcium score as an adjunct to nuclear myocardial perfusion imaging for risk stratification before noncardiac surgery. J Nucl Med 2012;53:1081-6.
40. Dodds TM, Stone JG, Coromilas J et al. Prophylactic nitroglycerin infusion during noncardiac surgery does not reduce perioperative ischemia. Anesth Analg 1993;76: 705-13.
41. Mangano DT, Layug EL, Wallace A et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996;335:1713-20.
42. Brady AR, Gibbs JS, Greenhalgh RM et al. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 2005;1:602-9.
43. Juul AB, Wetterslev J, Gluud C, Kofoed-Enevoldsen S, Jensen G, Callesen T et al. Effect of perioperative b blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. Br Med J 2006;332:1482.
44. Lindenauer PK, Pekow P, Wang K. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005;353:349-61.